Cargando…
Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe
The use of the rabies vaccine for post-exposure prophylaxis started as early as 1885, revealing a safe and efficient tool to prevent human rabies cases. Preventive vaccination is the basis for the control of canine-mediated rabies, which has already been eliminated from extensive parts of the world,...
Autores principales: | Echevarría, Juan E., Banyard, Ashley C., McElhinney, Lorraine M., Fooks, Anthony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832729/ https://www.ncbi.nlm.nih.gov/pubmed/31554170 http://dx.doi.org/10.3390/v11100892 |
Ejemplares similares
-
Ikoma Lyssavirus, Highly Divergent Novel Lyssavirus in an African Civet
por: Marston, Denise A., et al.
Publicado: (2012) -
Rabies in the African Civet: An Incidental Host for Lyssaviruses?
por: Sabeta, Claude T., et al.
Publicado: (2020) -
Current status of rabies and prospects for elimination
por: Fooks, Anthony R, et al.
Publicado: (2014) -
Complete Genome Sequence of Lleida Bat Lyssavirus
por: Marston, Denise A., et al.
Publicado: (2017) -
Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein
por: Marston, Denise A., et al.
Publicado: (2013)